Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Pairing HCV testing and treatment eliminates the need to navigate the medical system.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
People who received a shortened course of antiviral therapy were less likely to be cured.
The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.
After inmates filed a class action lawsuit, Nevada agreed to treat all prisoners living with hepatitis C.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
The drug can quickly reverse opioid-driven overdoses.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.